Showing results (391-400 of 404) with videos related to
Sort By:
Pageof 41
Circulation|December 13, 1997
Effect of nadroparin, a low-molecular-weight heparin, on clinical and angiographic restenosis after coronary balloon angioplasty: the FACT study. Fraxiparine Angioplastie Coronaire TransluminaleJ M Lablanche, E P McFadden, N Meneveau, et al.Nature Communications|April 16, 2021
Democratising deep learning for microscopy with ZeroCostDL4MicLucas von Chamier, Romain F Laine, Johanna Jukkala, et al.Archives of Dermatology|June 30, 1998
Topical metronidazole maintains remissions of rosaceaM V Dahl, H I Katz, G G Krueger, et al.Developmental Cell|June 9, 2015
MIM-Induced Membrane Bending Promotes Dendritic Spine InitiationJuha Saarikangas, Nazim Kourdougli, Yosuke Senju, et al.Nature Medicine|February 4, 1999
Presenilin mutations associated with Alzheimer disease cause defective intracellular trafficking of beta-catenin, a component of the presenilin protein complexM Nishimura, G Yu, G Levesque, et al.Journal of Cell Science|March 17, 2011
Missing-in-metastasis MIM/MTSS1 promotes actin assembly at intercellular junctions and is required for integrity of kidney epitheliaJuha Saarikangas, Pieta K Mattila, Markku Varjosalo, et al.Prenatal Diagnosis|November 14, 2012
What do French patients and geneticists think about prenatal and preimplantation diagnoses in Marfan syndrome?F Coron, T Rousseau, G Jondeau, et al.American Journal of Medical Genetics. Part A|April 9, 2009
Pathogenic FBN1 mutations in 146 adults not meeting clinical diagnostic criteria for Marfan syndrome: further delineation of type 1 fibrillinopathies and focus on patients with an isolated major criterionL Faivre, G Collod-Beroud, B Callewaert, et al.European Journal of Human Genetics : EJHG|November 13, 2008
Clinical and mutation-type analysis from an international series of 198 probands with a pathogenic FBN1 exons 24-32 mutationL Faivre, G Collod-Beroud, B Callewaert, et al.Pageof 41